GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.

OTCPK:GBGPF - Post by User

GB Group Ord Shs > 43.00 per share

<< Previous

Bullboard Posts

Next >>

Comment by dionsayson Jan 24, 2018 10:07am

82 Views

Post# 27422950

RE:RE:RE:RE:RE:RE:43.00 per share

Under the New Offer, CanniMed shareholders may receive in respect of each CanniMed share, 3.40 Aurora shares or a combination of cash and shares at the election of each CanniMed Shareholder, subject to pro-ration with the maximum aggregate cash consideration of $140 million. Based on an implied Aurora share price of $12.65 and the 3.40 exchange ratio, the New Offer would equate to $43.00, representing a 181% premium over the closing price of CanniMed Shares on November 14, 2017, the last day prior to the public disclosure of Aurora’s intention to pursue a combination with CanniMed, and a 79% increase to the previous offer Cap Price of $24.00.

The total consideration for CanniMed under the New Offer is approximately $1.1 billion based on Aurora’s implied share price of $12.65. The maximum amount of cash available under the amended offer will be $140 million, and the number of Aurora shares to be issued will be between approximately 72 million (assuming full cash elections) and 84 million (assuming full share elections and no cash elections). Assuming maximum cash elections, each CanniMed shareholder would receive $5.70 in cash and 2.9493 Aurora shares.

Read more at https://www.stockhouse.com/companies/bullboard#zzgeOYkUk6AZ7Qkp.99

Sledd66 wrote:

Salpal1 wrote: You are absolutely correct. Nobody seems to understand this deal. Its simple you are getting 2.94 shares of acb at $15 = $44.10 + $5.70 in cash. That's about $50. I just sold all my acb to buy CMED.

the 3.4 shares is better with no cash. Its 0.5 aurora shares for 5.70. Would you sell half of aurora for 5.70? Or basically 11.40 for 1 aurora? Your better off with the all paper ratio over the cash option